St Renatus patent expiration

1. Kovanaze patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6413499 ST RENATUS Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic
Mar, 2020

(4 years ago)

US8580282 ST RENATUS Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
Apr, 2030

(5 years from now)

US9308191 ST RENATUS Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
Apr, 2030

(5 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Combination(NC) Jun 29, 2019

Drugs and Companies using OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE ingredient

Market Authorisation Date: 29 June, 2016

Treatment: Method of anesthetizing at least a portion of the maxillary dental arch

Dosage: SPRAY, METERED

More Information on Dosage

KOVANAZE family patents

Family Patents